Options Brief: Alexion Pharmaceuticals

Shares of Alexion Pharmaceuticals ALXN are higher on the session by 4.29%, trading at $50.11. Overall call volume is now running at 4.99x the daily average, with 86% of all calls traded being purchases on the offer. 3,010 contracts have traded on the session so far. Alexion Pharmaceuticals, Inc. is a biopharmaceutical company engaged in the discovery, development and commercialization of therapeutic products aimed at treating patients with severe and life-threatening disease states, including those in the therapeutic areas of hematology, nephrology (including transplant rejection), neurology, ophthalmology and cancer.